Correlation Between COSCIENS Biopharma and Universal Music

Can any of the company-specific risk be diversified away by investing in both COSCIENS Biopharma and Universal Music at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining COSCIENS Biopharma and Universal Music into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between COSCIENS Biopharma and Universal Music Group, you can compare the effects of market volatilities on COSCIENS Biopharma and Universal Music and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in COSCIENS Biopharma with a short position of Universal Music. Check out your portfolio center. Please also check ongoing floating volatility patterns of COSCIENS Biopharma and Universal Music.

Diversification Opportunities for COSCIENS Biopharma and Universal Music

0.57

Correlation Coefficient

COSCIENS Biopharma  Universal Music

Very weak diversification

The 3 months correlation between COSCIENS and Universal is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding COSCIENS Biopharma and Universal Music Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Universal Music Group and COSCIENS Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on COSCIENS Biopharma are associated (or correlated) with Universal Music. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Universal Music Group has no effect on the direction of COSCIENS Biopharma i.e., COSCIENS Biopharma and Universal Music go up and down completely randomly.

Pair Corralation between COSCIENS Biopharma and Universal Music

Given the investment horizon of 90 days COSCIENS Biopharma is expected to under-perform the Universal Music. In addition to that, COSCIENS Biopharma is 1.6 times more volatile than Universal Music Group. It trades about -0.11 of its total potential returns per unit of risk. Universal Music Group is currently generating about -0.04 per unit of volatility. If you would invest  3,029  in Universal Music Group on September 21, 2024 and sell it today you would lose (440.00) from holding Universal Music Group or give up 14.53% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

COSCIENS Biopharma  vs.  Universal Music Group

COSCIENS Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days COSCIENS Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Universal Music Group

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Universal Music Group are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Universal Music is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with COSCIENS Biopharma and Universal Music

The main advantage of trading using opposite COSCIENS Biopharma and Universal Music positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if COSCIENS Biopharma position performs unexpectedly, Universal Music can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Universal Music will offset losses from the drop in Universal Music's long position.

The idea behind COSCIENS Biopharma and Universal Music Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.